Dianabol vs AnadrolMethandrostenolone vs Oxymetholone — Oral AAS Comparison by QSC Peptides

The Estrogenic Mechanism Difference

This is the most scientifically important distinction between Dianabol and Anadrol. Dianabol aromatizes via CYP19A1 to 17α-methylestradiol (MeE2) — a potent ER agonist that's more resistant to hepatic degradation than native estradiol, making Dianabol's estrogenic activity especially pronounced. Aromatase inhibitors (Aromasin, Arimidex) block this pathway.

Anadrol, despite being a DHT derivative (which cannot aromatize), exerts significant estrogenic effects through a completely different mechanism: it is a direct agonist at the estrogen receptor. This direct ER binding is unaffected by aromatase inhibitors, making Anadrol's estrogenic activity AI-resistant — a crucial consideration in AAS research design.

Research Protocol Selection

• Use Dianabol when studying aromatization-dependent estrogenic effects of oral AAS, MeE2 pharmacology, or when AI co-administration will control estrogen as a variable
• Use Anadrol when studying direct ER agonism from a non-aromatizing compound, comparing AI-sensitive vs AI-resistant estrogenic AAS, or when maximum acute anabolic response is the endpoint (320:45 ratio)

Dianabol's Injectable Form

QSC Peptides uniquely offers injectable Dianabol oil (50mg/mL) alongside oral tablets, enabling bioavailability comparison studies and first-pass bypass research that cannot be done with Anadrol's oral-only format.

Bulk Research — Dianabol 1000-Count

For large-scale in vitro research, QSC Peptides offers Dianabol 50mg tablets in 1000-count bulk (50,000mg total) — a format not available for Anadrol. This enables high-volume dissolution studies, receptor saturation experiments, and multi-well plate assays requiring large compound quantities.